Largest-ever US study on TB testing confirms benefits of IGRAs
The recent publication of the largest-ever US study comparing the use of TB blood tests (IGRAs) to the tuberculin skin test (TST) reaffirms current guidance regarding the preferred use of IGRAs for at-risk populations (1).
Including more than 20,000 participants across 10 US sites, the landmark US CDC-funded Tuberculosis Epidemiologic Studies Consortium (TBESC) study demonstrates that TB blood testing more accurately identifies latent TB among non-US-born individuals that have received the BCG vaccination, compared to TST.
Download the white paper now to learn more about this and other key findings that support the use of IGRA testing, including QuantiFERON®-TB Gold Plus, as a key tool in the global effort to end TB.
Thank you for your interest in our QIAGEN white papaer: Effectiveness of TB blood testing as a replacement for TB skin testing
* Mandatory fields